# US 2011/0236360 A1 · Lactic acid bacterium having high oxalic acid decomposition ability

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0236360 A1
- Document ID: US20110236360A1
- Status: Published application
- Kind: A1
- Application number: 13/119,382
- Filed: 2009-09-29
- Published: 2011-09-29
- Earliest claimed: 2008-09-30
- Assignees: Meiji Dairies Corporation
- Inventors: Daisuke Ochi; Hiroshi Tsuboi
- Web page: https://patentgrep.com/patent/US20110236360A1

## CPC

- A61K 35/74: Bacteria (therapeutic use of a bacterial protein A61K38/00)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 7/06: Antianaemics
- A61P 13/04: for urolithiasis
- A61P 13/12: of the kidneys
- A61P 19/10: for osteoporosis
- C12N 1/205: Bacterial isolates
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2400/145: Gasseri
- C12R 2001/225: Lactobacillus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention provides lactic acid bacteria having oxalic acid-degrading activity several times higher than those of conventionally known lactic acid bacteria having an oxalic acid-degrading activity, and uses thereof. Lactic acid bacteria capable of degrading a large amount of oxalic acid were screened from 132 strains of Lactobacillus lactic acid bacteria that have been independently isolated from feces and gastric juices of human adults. As a result, lactic acid bacteria having an oxalic acid degradation rate of 50% or more when cultured at 37° C. for 72 hours in a culture medium containing 10 mM oxalic acid at pH 6.5 at the start of culture were discovered.

## Claims

### Claim at position 1

-13. (canceled)

### Claim 14

A lactic acid bacterium belonging to the genus Lactobacillus, having an oxalic acid degradation rate of 50% or more when cultured at 37° C. for 72 hours in a culture medium containing 10 mM oxalic acid at pH 6.5 at the start of culture.

### Claim 15 (depends on 14)

The lactic acid bacterium of claim 14, wherein the lactic acid bacterium belonging to the genus Lactobacillus is the Lactobacillus gasseri species or the Lactobacillus amylovorus species.

### Claim 16

A lactic acid bacterium selected from the group consisting of (a) to (d) below:
(a) the Lactobacillus gasseri OLL203195 strain, which is a lactic acid bacterium deposited under Accession No. FERM BP-11005;
(b) the Lactobacillus amylovorus OLL2741 strain, which is a lactic acid bacterium deposited under Accession No. FERM BP-11007;
(c) the Lactobacillus amylovorus OLL2880 strain, which is a lactic acid bacterium deposited under Accession No. FERM BP-11006; and
(d) the Lactobacillus gasseri OLL2727 strain, which is a lactic acid bacterium deposited under Accession No. FERM BP-11004.

### Claim 17 (depends on 14)

A processed material of the lactic acid bacterium of claim 14.

### Claim 18 (depends on 16)

A processed material of the lactic acid bacterium of claim 16.

### Claim 19 (depends on 14)

A composition comprising the lactic acid bacterium of claim 14.

### Claim 20 (depends on 16)

A composition comprising the lactic acid bacterium of claim 16.

### Claim 21 (depends on 17)

A composition comprising the processed material of claim 17.

### Claim 22 (depends on 18)

A composition comprising the processed material of claim 18.

### Claim 23 (depends on 19)

The composition of claim 19 for treating and/or preventing renal/urinary calculus, anemia or osteoporosis.

### Claim 24 (depends on 20)

The composition of claim 20 for treating and/or preventing renal/urinary calculus, anemia or osteoporosis.

### Claim 25 (depends on 21)

The composition of claim 21 for treating and/or preventing renal/urinary calculus, anemia or osteoporosis.

### Claim 26 (depends on 22)

The composition of claim 22 for treating and/or preventing renal/urinary calculus, anemia or osteoporosis.

### Claim 27 (depends on 19)

The composition of claim 19, which is a pharmaceutical composition or food composition.

### Claim 28 (depends on 20)

The composition of claim 20, which is a pharmaceutical composition or food composition.

### Claim 29 (depends on 21)

The composition of claim 21, which is a pharmaceutical composition or food composition.

### Claim 30 (depends on 22)

The composition of claim 22, which is a pharmaceutical composition or food composition.

### Claim 31 (depends on 23)

The composition of claim 23, which is a pharmaceutical composition or food composition.

### Claim 32 (depends on 24)

The composition of claim 24, which is a pharmaceutical composition or food composition.

### Claim 33 (depends on 25)

The composition of claim 25, which is a pharmaceutical composition or food composition.

### Claim 34 (depends on 26)

The composition of claim 26, which is a pharmaceutical composition or food composition.

### Claim 35 (depends on 14)

A method for degrading oxalic acid or an oxalate compound or producing a composition with reduced levels of oxalic acid or oxalate compound, wherein the method comprises the step of contacting oxalic acid or an oxalate compound with the lactic acid bacterium of claim 14.

### Claim 36 (depends on 16)

A method for degrading oxalic acid or an oxalate compound or producing a composition with reduced levels of oxalic acid or oxalate compound, wherein the method comprises the step of contacting oxalic acid or an oxalate compound with the lactic acid bacterium of claim 16.

### Claim 37 (depends on 17)

A method for degrading oxalic acid or an oxalate compound or producing a composition with reduced levels of oxalic acid or oxalate compound, wherein the method comprises the step of contacting oxalic acid or an oxalate compound with the processed material of claim 17.

### Claim 38 (depends on 18)

A method for degrading oxalic acid or an oxalate compound or producing a composition with reduced levels of oxalic acid or oxalate compound, wherein the method comprises the step of contacting oxalic acid or an oxalate compound with the processed material of claim 18.

### Claim 39 (depends on 14)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the lactic acid bacterium of claim 14 to a subject.

### Claim 40 (depends on 16)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the lactic acid bacterium of claim 16 to a subject.

### Claim 41 (depends on 17)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the processed material of claim 17 to a subject.

### Claim 42 (depends on 18)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the processed material of claim 18 to a subject.

### Claim 43 (depends on 19)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the composition of claim 19 to a subject.

### Claim 44 (depends on 20)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the composition of claim 20 to a subject.

### Claim 45 (depends on 21)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the composition of claim 21 to a subject.

### Claim 46 (depends on 22)

A method for treating and/or preventing renal/urinary calculus, anemia, or osteoporosis, which comprises the step of administering the composition of claim 22 to a subject.
